VCYT Similar Chart Price Prediction
The price of VCYT is predicted to go up -12.34%, based on the high correlation periods with CYRX. The similarity of these two price pattern on the periods is 93.45%.
VCYT
CYRX
Down: -12.34%Similarity: 93.45%
VCYT Revenue Forecast
VCYT EPS Forecast
VCYT FAQs
What is bull’s view on VCYT?
What is bear's view on VCYT?
What is VCYT revenue forecast for next quarter？
What is VCYT eps forecast for next quarter？
VCYT Analyst's Forecast
Tejas Savant
Morgan Stanley
Sell
2024-11-18
Price Target
$26 → $28
Downside
-23.73%
Morgan Stanley raised the firm's price target on Veracyte to $28 from $26 and keeps an Underweight rating on the shares following a "decent" Q3 report. FY24 guidance was raised for that beat and an improved Q4 outlook and early color on FY25 was "encouraging," but the recent run up in the stock implies momentum is baked-in, while meaningful upside from nasal swab, IVD and MRD "will take time," the analyst tells investors.
Puneet Souda
Leerink Partners
Buy
2024-10-17
Price Target
$35 → $40
Upside
+16.58%
Subbu Nambi
Guggenheim
Strong Buy
2024-10-10
Price Target
$40
Upside
+23.95%
